Revolution Medicines Inc. [NASDAQ: RVMD] stock went on an upward path that rose over 4.49% on Monday, amounting to a one-week price increase of more than 1.24%. The one-year Revolution Medicines Inc. stock forecast points to a potential upside of 18.6. The average equity rating for RVMD stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $2.34 billion, with 59.00 million shares outstanding and 57.87 million shares in the current float. Compared to the average trading volume of 219.23K shares, RVMD stock reached a trading volume of 159365 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Revolution Medicines Inc. [RVMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVMD shares is $48.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVMD stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Revolution Medicines Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 21, 2020. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on March 09, 2020, representing the official price target for Revolution Medicines Inc. stock. Previously, the target price had yet another raise to $50, while Guggenheim analysts kept a Buy rating on RVMD stock.
The Average True Range (ATR) for Revolution Medicines Inc. is set at 3.13, with the Price to Sales ratio for RVMD stock in the period of the last 12 months amounting to 48.41. The Price to Book ratio for the last quarter was 6.02, with the Price to Cash per share for the same quarter was set at 5.84.
RVMD Stock Performance Analysis:
Revolution Medicines Inc. [RVMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.24.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RVMD stock in for the last two-week period is set at 62.50, with the RSI for the last a single of trading hit 65.06, and the three-weeks RSI is set at 60.19 for Revolution Medicines Inc. [RVMD]. The present Moving Average for the last 50 days of trading for this stock 32.49, while it was recorded at 37.92 for the last single week of trading.
Insight into Revolution Medicines Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Revolution Medicines Inc. [RVMD] shares currently have an operating margin of -106.96. Revolution Medicines Inc.’s Net Margin is presently recorded at -95.25.
Return on Total Capital for RVMD is now -42.90, given the latest momentum, and Return on Invested Capital for the company is -38.25. Return on Equity for this stock declined to -38.25, with Return on Assets sitting at -23.55. When it comes to the capital structure of this company, Revolution Medicines Inc. [RVMD] has a Total Debt to Total Equity ratio set at 0.11. Additionally, RVMD Total Debt to Total Capital is recorded at 0.11, with Total Debt to Total Assets ending up at 0.07.
Reflecting on the efficiency of the workforce at the company, Revolution Medicines Inc. [RVMD] managed to generate an average of -$501,726 per employee. Receivables Turnover for the company is 6.24 with a Total Asset Turnover recorded at a value of 0.25.Revolution Medicines Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.70 and a Current Ratio set at 8.70.
Revolution Medicines Inc. [RVMD] Insider Position Details
There are presently around $1,762 million, or 79.40% of RVMD stock, in the hands of institutional investors. The top three institutional holders of RVMD stocks are: TRV GP III, LLC with ownership of 9,024,031, which is approximately New of the company’s market cap and around 0.50% of the total institutional ownership; SVENNILSON PETER, holding 7,977,384 shares of the stock with an approximate value of $300.35 million in RVMD stocks shares; and FMR LLC, currently with $250.9 million in RVMD stock with ownership of nearly New of the company’s market capitalization.
72 institutional holders increased their position in Revolution Medicines Inc. [NASDAQ:RVMD] by around 46,811,274 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 46,811,274 shares, according to the latest SEC report filing. RVMD stock had 72 new institutional investments in for a total of 46,811,274 shares, while 0 institutional investors sold positions of 0 shares during the same period.